Characterization of IMG Microglial Cell Line as a Valuable In Vitro Tool for NLRP3 Inflammasome Studies

Janeli Viil1, Kelli Somelar-Duracz2, Külli Jaako2

  • 1Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu, 19 Ravila Street, 50411, Tartu, Estonia. janeli.viil@ut.ee.

Insights

The IMG mouse microglial cell line effectively models nucleotide-binding oligomerization domain-, leucine-rich repeat-, and pyrin domain-containing 3 (NLRP3) inflammasome activation. Short lipopolysaccharide (LPS) incubation with ATP robustly activates NLRP3 inflammasome signaling in IMG cells.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial cells are key immune cells in the brain, mediating inflammatory responses to injury and disease.
  • The nucleotide-binding oligomerization domain-, leucine-rich repeat-, and pyrin domain-containing 3 (NLRP3) inflammasome in microglia is implicated in neurological disorders.
  • Microglial cell lines are essential tools for studying neuroinflammation and potential therapeutic interventions.

Purpose of the Study:

  • To evaluate the suitability of the mouse microglial cell line IMG for studying NLRP3 inflammasome activation.
  • To compare the response of IMG cells to varying concentrations and incubation times of lipopolysaccharide (LPS) and ATP.
  • To assess the efficacy of the NLRP3 inflammasome inhibitor glibenclamide in IMG cells.

Main Methods:

  • IMG cells were treated with different concentrations of lipopolysaccharide (LPS) for short (4h) or long (24h) durations, followed by ATP stimulation.
  • Gene and protein expression levels of pro-inflammatory markers and NLRP3 inflammasome components (caspase-1, IL-1β) were analyzed.
  • Experiments were also performed on primary microglial cells and the BV-2 cell line for comparative analysis.

Main Results:

  • Short (4h) LPS incubation led to greater upregulation of pro-inflammatory and NLRP3 inflammasome-associated genes compared to long (24h) incubation.
  • Higher concentrations of LPS and ATP combined with short incubation time resulted in increased active caspase-1 and IL-1β protein levels.
  • Glibenclamide treatment suppressed NLRP3 inflammasome activation in IMG cells, indicated by reduced gasdermin D N-fragment, mature caspase-1, and IL-1β.

Conclusions:

  • The IMG cell line is a valuable tool for investigating NLRP3 inflammasome activation in microglial cells.
  • A 4-hour LPS incubation followed by ATP stimulation is optimal for robust NLRP3 inflammasome activation in IMG cells.
  • These findings support the use of IMG cells for studying neuroinflammation and developing targeted therapies for neurological diseases.

Related Concept Videos